Prevalence and characterisation of plasmid-mediated quinolone resistance and mutations in the gyrase and topoisomerase IV genes among Shigella isolates from Henan, China, between 2001 and 2008 - PubMed (original) (raw)

Prevalence and characterisation of plasmid-mediated quinolone resistance and mutations in the gyrase and topoisomerase IV genes among Shigella isolates from Henan, China, between 2001 and 2008

Haiyan Yang et al. Int J Antimicrob Agents. 2013 Aug.

Abstract

A total of 293 Shigella isolates were isolated from patients with diarrhoea in four villages of Henan, China. This study investigated the prevalence of the plasmid-mediated quinolone resistance (PMQR) genes qnrA, qnrB, qnrS, qepA and aac(6')-Ib-cr and compared the polymorphic quinolone resistance-determining regions (QRDRs) of gyrA, gyrB, parC and parE. Of the isolates, 292 were found to be resistant to nalidixic acid and pipemidic acid, whereas 77 were resistant to ciprofloxacin (resistance rate of 26.3%). Resistance of the Shigella isolates to ciprofloxacin significantly increased from 2001 to 2008 (P<0.05). A mutation in gyrA was present in 277 (94.5%) of the isolates and a mutation in parC was present in 19 (6.5%) of the isolates. Moreover, 168 (57.3%) of the isolates contained only the gyrA (Ser83Leu) mutation. In addition, 107 isolates had two gyrA point mutations (Ser83Leu and either Asp87Gly, Asp87Asn or Asp113Tyr) and 13 isolates had two gyrA point mutations (Ser83Leu and Asp87Gly or Gly214Ala) and one parC mutation (Ser80Ile). In addition, qepA and aac(6')-Ib-cr were present in 6 (2.05%) and 19 (6.48%) of the isolates, respectively. All but one of the PMQR-positive isolates with a ciprofloxacin minimum inhibitory concentration in the range 4-32μg/mL had a mutation in the QRDR. It is known that PMQR-positive Shigella isolates are common in China. This study found that there was a significant increase in mutation rates of the QRDR and the resistant rates to ciprofloxacin. Other mechanisms may be present in the isolates that also contribute to their resistance to ciprofloxacin.

Keywords: China; Ciprofloxacin; PMQR; QRDR; Shigella.

PubMed Disclaimer

Cited by

Newest data on fluoroquinolone resistance mechanism of Shigella flexneri isolates in Jiangsu Province of China.
Qin T, Qian H, Fan W, Ma P, Zhou L, Dong C, Gu B, Huo X. Qin T, et al. Antimicrob Resist Infect Control. 2017 Sep 19;6:97. doi: 10.1186/s13756-017-0249-1. eCollection 2017. Antimicrob Resist Infect Control. 2017. PMID: 28932390 Free PMC article.
Shigella: Antibiotic-Resistance Mechanisms And New Horizons For Treatment.
Ranjbar R, Farahani A. Ranjbar R, et al. Infect Drug Resist. 2019 Oct 7;12:3137-3167. doi: 10.2147/IDR.S219755. eCollection 2019. Infect Drug Resist. 2019. PMID: 31632102 Free PMC article.
Molecular characterization of fluoroquinolone and/or cephalosporin resistance in Shigella sonnei isolates from yaks.
Zhu Z, Shi Y, Zhou X, Li B, Zhang J. Zhu Z, et al. BMC Vet Res. 2018 Jun 7;14(1):177. doi: 10.1186/s12917-018-1500-6. BMC Vet Res. 2018. PMID: 29879965 Free PMC article.
Resistance determinants and mobile genetic elements of an NDM-1-encoding Klebsiella pneumoniae strain.
Hudson CM, Bent ZW, Meagher RJ, Williams KP. Hudson CM, et al. PLoS One. 2014 Jun 6;9(6):e99209. doi: 10.1371/journal.pone.0099209. eCollection 2014. PLoS One. 2014. PMID: 24905728 Free PMC article.
Epidemic and molecular characterization of fluoroquinolone-resistant Shigella dysenteriae 1 isolates from calves with diarrhea.
Cao M, Wang W, Zhang L, Liu G, Zhou X, Li B, Shi Y, Zhu Z, Zhang J. Cao M, et al. BMC Microbiol. 2021 Jan 6;21(1):6. doi: 10.1186/s12866-020-02050-9. BMC Microbiol. 2021. PMID: 33407134 Free PMC article.

Prevalence and characterisation of plasmid-mediated quinolone resistance and mutations in the gyrase and topoisomerase IV genes among Shigella isolates from Henan, China, between 2001 and 2008 - PubMed (original) (raw)